New rabies shot could shield millions after bites
NCT ID NCT07445815
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a lab-made antibody injection designed to prevent rabies after exposure. About 200 healthy adults aged 18-60 will receive the injection to check its safety and how well it boosts rabies-fighting antibodies. The goal is to find a reliable treatment that can be used after a potential rabies exposure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RABIES (HEALTHY VOLUNTEERS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Lanzhou Institute of Biological Products Co., Ltd.
Lanzhou, Gansu, 730000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Rabies vaccine booster still effective after 5 years, study to confirm
- Rabies vaccine batch check: will it pass the test?
- New rabies vaccine schedule tested in 2,000 volunteers
- New rabies vaccine shows promise in preventing deadly infection
- Promising new rabies vaccine passes phase 3 test
- New rabies vaccine shows promise in large thai trial